MFN Drug Pricing Targets: Lowering U.S. Drug Co...

By Rene Pretorius

May 21, 2025

Summary The U.S. Department of Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS) have set Most-Favored-Nation (MFN)
HTA Reform Analysis: Patterns and Global Trends in Health Technology Assessment
Drug Pricing Analysis: ICER’s Launch Price and Access Report Aims to En...
Trends in Anticancer Drug Pricing: Analyzing Medicare Launch Prices and Impac...
Evolving NICE Health Technology Evaluations: Enhancing Patient Perspectives a...
Canada Drug Agency Plan: Shaping the Future of Health Systems 2025-2030
Hepatitis C Investment Impact: Maximizing Health and Economic Returns in China
MR-107A-02: Revolutionizing Non-Opioid Pain Management with Viatris’ Breakthr...
Prevention Valuation: Fund Health, Not Just Savings
FDA AI Drug Approval
Implementing Health Technology Assessment in Oman
TAVR Asymptomatic Approval: A New Era for Early Intervention in Aortic Stenosis
Empowering Health: The Role of Self-Care and NCDs in Global Health Policy